Publication: Counterfeit anti-infective drugs
Issued Date
2006-09-01
Resource Type
ISSN
14733099
Other identifier(s)
2-s2.0-33747341277
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Lancet Infectious Diseases. Vol.6, No.9 (2006), 602-613
Suggested Citation
Paul N. Newton, Michael D. Green, Facundo M. Fernández, Nicholas PJ Day, Nicholas J. White Counterfeit anti-infective drugs. Lancet Infectious Diseases. Vol.6, No.9 (2006), 602-613. doi:10.1016/S1473-3099(06)70581-3 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/23638
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Counterfeit anti-infective drugs
Abstract
The production of counterfeit or substandard anti-infective drugs is a widespread and under-recognised problem that contributes to morbidity, mortality, and drug resistance, and leads to spurious reporting of resistance and toxicity and loss of confidence in health-care systems. Counterfeit drugs particularly affect the most disadvantaged people in poor countries. Although advances in forensic chemical analysis and simple field tests will enhance drug quality monitoring, improved access to inexpensive genuine medicines, support of drug regulatory authorities, more open reporting, vigorous law enforcement, and more international cooperation with determined political leadership will be essential to counter this threat. © 2006 Elsevier Ltd. All rights reserved.